High throughput LC-MS/MS method for the simultaneous analysis of multiple vitamin D analytes in serum

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1014, Issue , 2016, Pages 56-63

  Jenkinson, Carl ^a   Taylor, Angela E ^a   Hassan Smith, Zaki K ^a   Adams, John S ^b   Stewart, Paul M ^c   Hewison, Martin ^a   Keevil, Brian G ^d,e  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chiral separation; LC MS MS; Method validation; Serum analysis; Vitamin D

Indexed keywords

BIOMOLECULES; BODY FLUIDS; CHIRALITY; CHROMATOGRAPHY; HEALTH RISKS; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; METABOLITES; SEPARATION; THROUGHPUT;

CHIRAL SEPARATIONS; LC-MS/MS; METHOD VALIDATIONS; SERUM ANALYSIS; VITAMIN-D;

VITAMINS;

1,25 DIHYDROXYERGOCALCIFEROL; 1ALPHA 24 DIHYDROXYVITAMIN D2; 1APLHA 25 DIHYDROXYVITAMIN D3 D3; 24 HYDROXYVITAMIN 2; 25 HYDROXYERGOCALCIFEROL; 3 EPI 25 HYDROXYVITAMIN D2; 3 EPI 25 HYDROXYVITAMIN D3; 3 EPI HYDROXYVITAMIN D3; 7ALPHA HYDROXY 4 CHOLESTEN 3 ONE; CALCIFEDIOL; CALCITRIOL; COLECALCIFEROL; ERGOCALCIFEROL; ERGOCALCIFEROL D3; SECALCIFEROL; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EPIMER; FEMALE; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; METABOLITE; NORMAL HUMAN; PRECURSOR; PRIORITY JOURNAL; SEASONAL VARIATION; SERUM; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; BLOOD; METABOLISM; MIDDLE AGED; PROCEDURES; SEASON; VALIDATION STUDY; YOUNG ADULT;

ADULT; AGED; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; FEMALE; HUMANS; LIQUID-LIQUID EXTRACTION; MALE; MIDDLE AGED; SEASONS; TANDEM MASS SPECTROMETRY; VITAMIN D; VITAMINS; YOUNG ADULT;

EID: 84957641377     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2016.01.049     Document Type: Article

References (40)

1. Singh R.J., Taylor R.L., Reddy G.S., Grebe S.K.G. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J. Clin. Endocrinol. Metab. 2006, 91:3055-3061.
2. Farrell C., Martin S., Straub I., Williams P., McWhinney B., Herrmann M. State of the art of vitamin D assays: latest generation assays. Osteoporos. Int. 2011, 22:S583.
3. Holick M.F., Biancuzzo R.M., Chen T.C., Klein E.K., Young A., Bibuld D., Reitz R., Salameh W., Ameri A., Tannenbaum A.D. Vitamin D-2 is as effective as vitamin D-3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J. Clin. Endocrinol. Metab. 2008, 93:677-681.
4. Trang H.M., Cole D.E., Rubin L.A., Pierratos A., Siu S., Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am. J. Clin. Nutr. 1998, 68:854-858.
5. Higashi T., Shimada K., Toyo'oka T. Advances in determination of vitamin D related compounds in biological samples using liquid chromatography-mass spectrometry: a review. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2010, 878:1654-1661.
6. El-Khoury J.M., Reineks E.Z., Wang S.H. Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues. Clin. Biochem. 2011, 44:66-76.
7. Shah I., James R., Barker J., Petroczi A., Naughton D.P. Misleading measures in vitamin D analysis: a novel LC-MS/MS assay to account for epimers and isobars. Nutr. J. 2011, 10:46.
8. Lensmeyer G., Poquette M., Wiebe D., Binkley N. The C-3 epimer of 25-hydroxyvitamin D-3 is present in adult serum. J. Clin. Endocrinol. Metab. 2012, 97:163-168.
9. Reddy G.S., Muralidharan K.R., Okamura W.H., Tserng K.Y., Mclane J.A. Metabolism of 1 alpha 25-dihydroxyvitamin D-3 and one of its A-ring diastereomer 1 alpha 25-dihydroxy-3-epivitamin D-3 in neonatal human keratinocytes. Vitamin D: Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications 1994, 172-173.
10. Kadiyala S., Nagaba S., Takeuchi K., Yukihiro S., Qiu W., Eyes S.T., Uskokovic M.R., Posner G.H., Reddy G.S., Guggino S.E. Metabolites and analogs of 1alpha,25-dihydroxyvitamin D(3): evaluation of actions in bone. Steroids 2001, 66:347-355.
11. Brown A.J., Ritter C.S., Weiskopf A.S., Vouros P., Sasso G.J., Uskokovic M.R., Wang G., Reddy G.S. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion. J. Cell. Biochem. 2005, 96:569-578.
12. Wallace A.M., Gibson S., de la Hunty A., Lamberg-Allardt C., Ashwell M. Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids 2010, 75:477-488.
13. Carter G.D. 25-Hydroxyvitamin D assays: the quest for accuracy. Clin. Chem. 2009, 55:1300-1302.
14. Roth H.J., Schmidt-Gayk H., Weber H., Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann. Clin. Biochem. 2008, 45:153-159.
15. Hollis B.W., Horst R.L. The assessment of circulating 25(OH)D and 1,25(OH) 2D: where we are and where we are going. J. Steroid Biochem. Mol. Biol. 2007, 103:473-476.
16. Taylor A.E., Keevil B., Huhtaniemi I.T. Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow. Eur. J. Endocrinol. 2015, 173:D1-D12.
17. Vogeser M., Parhofer K.G. Liquid chromatography tandem-mass spectrometry (LC-MS/MS)-technique and applications in endocrinology. Exp. Clin. Endocrinol. Diabetes 2007, 115:559-570.
18. Wierman M.E., Auchus R.J., Haisenleder D.J., Hall J.E., Handelsman D., Hankinson S., Rosner W., Singh R.J., Sluss P.M., Stanczyk F.Z. Editorial: the new instructions to authors for the reporting of steroid hormone measurements. Endocrinology 2014, 155:4603.
19. Keevil B.G. Novel liquid chromatography tandem mass spectrometry (LC-MS/MS) methods for measuring steroids. Best Pract. Res. Clin. Endocrinol. Metab. 2013, 27:663-674.
20. U.S.F.a.D. Administration, Guidance for Industry Bioanalytical Method Validation, (2001).
21. Song D., Wang J. Modified resolution factor for asymmetrical peaks in chromatographic separation. J. Pharm. Biomed. Anal. 2003, 32:1105-1112.
22. Chailurkit L., Aekplakorn W., Ongphiphadhanakul B. Serum C3 epimer of 25-hydroxyvitamin D and its determinants in adults: a national health examination survey in Thais. Osteoporos. Int. 2015, 10.1007/s00198-015-3125-y.
23. Lutsey P.L., Eckfeldt J.H., Ogagarue E.R., Folsom A.R., Michos E.D., Gross M. The 25-hydroxyvitamin D3 C-3 epimer: distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC). Clin. Chim. Acta 2015, 442:75-81.
24. Wagner D., Hanwell H.E., Schnabl K., Yazdanpanah M., Kimball S., Fu L., Sidhom G., Rousseau D., Cole D.E., Vieth R. The ratio of serum 24,25-dihydroxyvitamin D(3) to 25-hydroxyvitamin D(3) is predictive of 25-hydroxyvitamin D(3) response to vitamin D(3) supplementation. J. Steroid Biochem. Mol. Biol. 2011, 126:72-77.
25. Muller M.J., Volmer D.A. Mass spectrometric profiling of vitamin D metabolites beyond 25-hydroxyvitamin D. Clin. Chem. 2015, 10.1373/clinchem.2015.241430.
26. Schlingmann K.P., Kaufmann M., Weber S., Irwin A., Goos C., John U., Misselwitz J., Klaus G., Kuwertz-Broking E., Fehrenbach H., Wingen A.M., Guran T., Hoenderop J.G., Bindels R.J., Prosser D.E., Jones G., Konrad M. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N. Engl. J. Med. 2011, 365:410-421.
27. Muindi J.R., Yu W.D., Ma Y., Engler K.L., Kong R.X., Trump D.L., Johnson C.S. CYP24A1 inhibition enhances the antitumor activity of calcitriol. Endocrinology 2010, 151:4301-4312.
28. Horvath H.C., Lakatos P., Kosa J.P., Bacsi K., Borka K., Bises G., Nittke T., Hershberger P.A., Speer G., Kallay E. The candidate oncogene CYP24A1: a potential biomarker for colorectal tumorigenesis. J. Histochem. Cytochem. 2010, 58:277-285.
29. Bailey D., Veljkovic K., Yazdanpanah M., Adeli K. Analytical measurement and clinical relevance of vitamin D(3) C3-epimer. Clin. Biochem. 2013, 46:190-196.
30. van den Ouweland J.M.W., Beijers A.M., van Daal H. Fastseparation of 25-hydroxyvitamin D-3 from 3-epi-25-hydroxyvitamin D-3 in human serum by liquid chromatography-tandem mass spectrometry: variable prevalence of 3-epi-25-hydroxyvitamin D-3 in infants, children, and adults. Clin. Chem. 2011, 57:1618-1619.
31. Wright M.J.P., Halsall D.J., Keevil B.G. Removal of 3-epi-25-hydroxyvitamin D-3 interference by liquid chromatography-tandem mass spectrometry is not required for the measurement of 25-hydroxyvitamin D-3 in patients older than 2 years. Clin. Chem. 2012, 58:1719-1720.
32. Clarke M.W., Tuckey R.C., Gorman S., Holt B., Hart P.H. Optimized 25-hydroxyvitamin D analysis using liquid-liquid extraction with 2D separation with LC/MS/MS detection, provides superior precision compared to conventional assays. Metabolomics 2013, 9:1031-1040.
33. Yetley E.A., Pfeiffer C.M., Schleicher R.L., Phinney K.W., Lacher D.A., Christakos S., Eckfeldt J.H., Fleet J.C., Howard G., Hoofnagle A.N., Hui S.L., Lensmeyer G.L., Massaro J., Peacock M., Rosner B., Wiebe D., Bailey R.L., Coates P.M., Looker A.C., Sempos C., Johnson C.L., Picciano M.F. NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J. Nutr. 2010, 140:2030S-2045S.
34. Yazdanpanah M., Bailey D., Walsh W., Wan B., Adeli K. Analytical measurement of serum 25-OH-vitamin D(3), 25-OH-vitamin D(2) and their C3-epimers by LC-MS/MS in infant and pediatric specimens. Clin. Biochem. 2013, 46:1264-1271.
35. Armas L.A.G., Hollis B.W., Heaney R.P. Vitamin D(2) is much less effective than vitamin D(3) in humans. J. Clin. Endocrinol. Metab. 2004, 89:5387-5391.
36. B.M.A.a.R.P.S.o.G. Britain British National Formulary Vitamin D, (2015).
37. Ross A.C., Manson J.E., Abrams S.A., Aloia J.F., Brannon P.M., Clinton S.K., Durazo-Arvizu R.A., Gallagher J.C., Gallo R.L., Jones G., Kovacs C.S., Mayne S.T., Rosen C.J., Shapses S.A. The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 2011, 96:53-58.
38. Mawer E.B., Hayes M.E., Still P.E., Davies M., Lumb G.A., Palit J., Holt P.J. Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin in patients with inflammatory arthritis. J. Bone Miner. Res. 1991, 6:733-739.
39. Tanaka Y., DeLuca H.F., Schnoes H.K., Ikekawa N., Eguchi T. 23,25-Dihydroxyvitamin D3: a natural precursor in the biosynthesis of 25-hydroxyvitamin D3-26,23-lactone. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:4805-4808.
40. Hewison M. Vitamin D and the intracrinology of innate immunity. Mol. Cell. Endocrinol. 2010, 321:103-111.